Elevance Health (NYSE:ELV – Get Free Report) was downgraded by investment analysts at StockNews.com from a “buy” rating to a “hold” rating in a research note issued to investors on Wednesday. A number ...

Daneshvar Rohinton of iA Global Asset Management is expecting an economic realignment as many countries look at becoming more ...

Elevance Health’s Executive VP Charles Kendrick sold $1.4M worth of stock, reducing his stake by 40%. While insider sales can ...

Elevance Health Inc. closed 26.44% below its 52-week high of $567.26, which the company reached on September 3rd.

In a recently published Perspective article in the New England Journal of Medicine, Marisha Burden, MD, MBA, and Liselotte ...

Meet the Innovators of the Year for Senior Health honorees for Atlanta Business Chronicle's Health Care Champion Awards.

Regulatory changes under Trump's administration and AI integration are key factors influencing Elevance Health's future ...

Shares of Elevance Health, Inc. (NYSE:ELV – Get Free Report) have been assigned an average rating of “Moderate Buy” from the ...

Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our ...

Elevance Health received a consensus analyst rating of "Moderate Buy," indicating confidence in the company's potential. Out ...

Health insurance companies appear to be denying a growing share of patient claims. Why?

Rising Dividend Fund A Shares (without sales charge*) posted a return of -5.60% in fourth quarter 2024. Read more here.